PCM
MDCO

Piermont Capital Management’s Medicines Co MDCO Stock Holding History

Piermont Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,720
Closed -$284K – 214
2014
Q3 		$284K Buy
12,720
+5,680
+81% +$144K 0.11% 171
2014
Q2 		$205K Hold
7,040
– – 0.08% 132
2014
Q1 		$200K Hold
7,040
– – 0.1% 131
2013
Q4 		$272K Buy
+7,040
New +$252K 0.14% 104

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Piermont Capital Management's MDCO Position: Q4 2014 in Review

Piermont Capital Management sold out of Medicines Co (MDCO) in Q4 2014, closing a stake of 12,720 shares — an estimated $284K sold.

Piermont Capital Management first reported a position in MDCO in Q4 2013 and held it in 4 quarters. The position peaked at $284K in Q3 2014. 166 funds tracked by Wall St. Rank hold MDCO as of Q4 2014.

  • Piermont Capital Management reported no remaining Medicines Co position as of Q4 2014 after selling out during the quarter.
  • Piermont Capital Management sold 12,720 Medicines Co shares in Q4 2014, an estimated $284K.
  • Piermont Capital Management first reported a position in Medicines Co in Q4 2013 and held it in 4 quarters.
  • Piermont Capital Management's Medicines Co position peaked at $284K in Q3 2014.
  • 166 funds tracked by Wall St. Rank held Medicines Co as of Q4 2014.

Based on Piermont Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.